BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 29775756)

  • 1. PKM2, a potential target for regulating cancer.
    Li YH; Li XF; Liu JT; Wang H; Fan LL; Li J; Sun GP
    Gene; 2018 Aug; 668():48-53. PubMed ID: 29775756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-metabolic functions of pyruvate kinase M2: PKM2 in tumorigenesis and therapy resistance.
    İlhan M
    Neoplasma; 2022 Jul; 69(4):747-754. PubMed ID: 35471978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyruvate kinase M2: A simple molecule with complex functions.
    Alquraishi M; Puckett DL; Alani DS; Humidat AS; Frankel VD; Donohoe DR; Whelan J; Bettaieb A
    Free Radic Biol Med; 2019 Nov; 143():176-192. PubMed ID: 31401304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs.
    Puckett DL; Alquraishi M; Chowanadisai W; Bettaieb A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of Evidence for PKM2 Protein Kinase Activity.
    Hosios AM; Fiske BP; Gui DY; Vander Heiden MG
    Mol Cell; 2015 Sep; 59(5):850-7. PubMed ID: 26300261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer.
    Chaneton B; Gottlieb E
    Trends Biochem Sci; 2012 Aug; 37(8):309-16. PubMed ID: 22626471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyruvate kinase M2: A multifarious enzyme in non-canonical localization to promote cancer progression.
    Amin S; Yang P; Li Z
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):331-341. PubMed ID: 30826427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism.
    Shiroki T; Yokoyama M; Tanuma N; Maejima R; Tamai K; Yamaguchi K; Oikawa T; Noguchi T; Miura K; Fujiya T; Shima H; Sato I; Murata-Kamiya N; Hatakeyama M; Iijima K; Shimosegawa T; Satoh K
    Cancer Sci; 2017 May; 108(5):931-940. PubMed ID: 28235245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species.
    Yokoyama M; Tanuma N; Shibuya R; Shiroki T; Abue M; Yamamoto K; Miura K; Yamaguchi K; Sato I; Tamai K; Satoh K
    Int J Oncol; 2018 Mar; 52(3):881-891. PubMed ID: 29393401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of Pyruvate Kinase M2 Inhibits Cell Proliferation, Metabolism, and Migration in Renal Cell Carcinoma.
    Dey P; Son JY; Kundu A; Kim KS; Lee Y; Yoon K; Yoon S; Lee BM; Nam KT; Kim HS
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activators of PKM2 in cancer metabolism.
    Warner SL; Carpenter KJ; Bearss DJ
    Future Med Chem; 2014 Jun; 6(10):1167-78. PubMed ID: 25078136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKM2, cancer metabolism, and the road ahead.
    Dayton TL; Jacks T; Vander Heiden MG
    EMBO Rep; 2016 Dec; 17(12):1721-1730. PubMed ID: 27856534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target.
    van Niekerk G; Engelbrecht AM
    Cell Oncol (Dordr); 2018 Aug; 41(4):343-351. PubMed ID: 29797241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer.
    Tang R; Yang C; Ma X; Wang Y; Luo D; Huang C; Xu Z; Liu P; Yang L
    Oncotarget; 2016 Feb; 7(5):5972-84. PubMed ID: 26745603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
    Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Pyruvate Kinase Type M2 (PKM2) Promotes Ovarian Cancer Cell Growth and Survival Via Regulation of Cell Cycle Progression Related with Upregulated CCND1 and Downregulated CDKN1A Expression.
    Zheng B; Liu F; Zeng L; Geng L; Ouyang X; Wang K; Huang Q
    Med Sci Monit; 2018 May; 24():3103-3112. PubMed ID: 29752805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolism enzyme controls cancer stemness].
    Konno M; Doki Y; Mori M; Ishii H
    Nihon Rinsho; 2015 May; 73(5):745-50. PubMed ID: 25985625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyruvate kinase: Function, regulation and role in cancer.
    Israelsen WJ; Vander Heiden MG
    Semin Cell Dev Biol; 2015 Jul; 43():43-51. PubMed ID: 26277545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics.
    Zhu S; Guo Y; Zhang X; Liu H; Yin M; Chen X; Peng C
    Cancer Lett; 2021 Apr; 503():240-248. PubMed ID: 33246091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moderate DNA damage promotes metabolic flux into PPP via PKM2 Y-105 phosphorylation: a feature that favours cancer cells.
    Kumar B; Bamezai RN
    Mol Biol Rep; 2015 Aug; 42(8):1317-21. PubMed ID: 25840825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.